Günther Wess1, Matthias Urmann, Birgitt Sickenberger. 1. Aventis Pharma Deutschland GmbH Head of Drug Innovation & Approval (DI&A) Deutschland Building H 825, Industriepark Höchst, 65926 Frankfurt (Germany).
Authors: Olivier Civelli; Rainer K Reinscheid; Yan Zhang; Zhiwei Wang; Robert Fredriksson; Helgi B Schiöth Journal: Annu Rev Pharmacol Toxicol Date: 2012-09-28 Impact factor: 13.820
Authors: Kevin X Rodriguez; Erin N Howe; Emily P Bacher; Miranda Burnette; Jennifer L Meloche; Jayda Meisel; Patricia Schnepp; Xuejuan Tan; Mayland Chang; Jeremiah Zartman; Siyuan Zhang; Brandon L Ashfeld Journal: ChemMedChem Date: 2019-07-01 Impact factor: 3.466
Authors: Garrett M Morris; Luke G Green; Zoran Radić; Palmer Taylor; K Barry Sharpless; Arthur J Olson; Flavio Grynszpan Journal: J Chem Inf Model Date: 2013-03-29 Impact factor: 4.956